Turn Therapeutics, a biotechnology company specializing in advanced wound care and infection control, today announced enrollment of the first subjects in its COVID-19 treatment and prevention clinical ...

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.

TORONTO, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research ...

ZURICH, Feb 8 (Reuters) - Relief Therapeutics Holding (RLFB.S), opens new tab expects top-line data from a trial of RLF-100 used intravenously in patients with COVID-19 to be released this month, the ...

When most of us were reinfected in January this year, I was disappointed, given that we are up to date with vaccinations and generally wear masks in high-risk settings. But reinfection is the norm for ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...